No, scientists are not any closer to pig-to-human transplants than they were last week
By Jason Mast,
Endpoints News
| 10. 22. 2021
Steve Holtzman was awoken by a 1 a.m. call from a doctor at Duke University asking if he could put some pigs on a plane and fly them from Ohio to North Carolina that day. A motorcyclist had gotten into a horrific crash, the doctor explained. He believed the pigs’ livers, sutured onto the patient’s skin like an external filter, might be able to tide the young man over until a donor liver became available.
Holtzman was the president of DNX, one of the first companies to try to use biotechnology to make pig-to-human transplants possible. He had amassed a pathogen-free porcine facility for their work and so obliged, putting some unlucky hogs on an Ohio State University plane to Duke, where one of ultimately four patients treated with the procedure survived to receive a new human liver. The results were published in the New England Journal of Medicine in 1994.
Which is why Holtzman was shocked and a little bit confused when he read reports this week that doctors at NYU had conducted a “groundbreaking” procedure by, with the...
Related Articles
By Isaac Schultz, Gizmodo | 10.18.2024
Colossal Biosciences, a company mainly known for intending to genetically engineer proxies for several iconic extinct species, announced this week that it has made major steps towards the de-extinction of the thylacine, or Tasmanian tiger.
The thylacine was a carnivorous...
By Russ Burlingame, Comicbook | 07.23.2024
Colossal Laboratories and Biosciences, a biotech company that's putting together plans to orchestrate the de-extinction for animals like the dodo and the wooly mammoth, made some waves on Reddit recently when they petitioned the United Federation of Planets -- the...
By Shelly Fan, Singularity Hub | 05.31.2024
We all know the drill for reproduction—sperm meets egg.
For the past decade, scientists have been pushing the boundaries of where the two halves come from. Thanks to induced pluripotent stem cell technology, it’s now possible to scrape skin cells...
By Alison Snyder, Axios | 06.06.2024
Gene editing's next chapter will be focused on tackling cancers and more common diseases, uncovering new details about aging and other fundamental aspects of biology and editing RNA, top scientists in the field said this week.
The big picture: ...